Doug Godshall: Yeah. It’s an interesting dynamic, very different than say COVID where it would be like a wipe out in some areas. This is more — and I was going to — were comparing notes with Veeva last week and both have spent a bunch of time in the field. In some hospitals no difference. They’ve ratcheted down on travel nurses, gotten things under control in other areas. One big center I was talking to last week like they had a — they were struggling to even get travel nurses, so they were for a couple of weeks on sort of emergency cases only. So it’s pocketed. Certainly the — in the past, we’ve talked about staffing challenges being the new norm and I’d say they are the new norm, although they’re sort of severe centers of pockets and then no change whatsoever with momentum being quite strong in the procedure volume.
So, it’s not like a major downdraft, but it does affect volume when hospitals have to restrict cases. And so, it’s a factor. It’s — I wouldn’t say it’s — we’re certainly — obviously, we’re not terribly concerned other than it’s frustrating for our customers when they can’t get the cases done at the time they want to get them done.
Isaac Zacharias: Yes. And I’d just add to that, it’s not worsening. I mean, I’d say generally, across the US, the staffing is improving and has been this year. The — where we see some problems though, it will limit the ability of a typical Q4 surge of procedures if that center doesn’t have the staff to support it. And that’s where you’ll hear — that’s where we hear pockets of that happening. You’re not going to be able to get procedures going from Q3 to Q4 like you typically will, because they’re just not letting you schedule that many electives.
Michael Polark: Appreciate that color. And maybe for the follow-up on coronary, Isaac you provided a lot of good detail in your remarks and you said, hey you see accounts where penetration of PCI is low singles with IVL and you see accounts where consistently folks are mid-teens. And I guess, as you bridge that divide kind of what are the one, two or three things that stand out? What are the kind of — what’s the handholding and support that your team can provide to take that low single-digit account up towards 10 or beyond?
Isaac Zacharias: Yes, I think I mean, so probably the number one thing still is economics or perceived economics. And I think some centers — it may be our team, with some centers have done a better job of bridging that with the administration and that’s kind of an ongoing effort. And we talked about how we see that improving over the midterm. I think beyond that, our best centers are centers where you have — there might be five interventional cardiologists doing procedures there. And all five of them have kind of bought in and have adopted coronary IVL. And that — a physician at that center is as good as a physician as we have anywhere, but you’ll have other centers where you have a physician who’s doing a lot of complex work, they’ve bought in IVL and they’re doing it as appropriate and kind of where we see it should be, but you have other cardiologists at that center who for any number of reasons, we haven’t been able to spend enough time with or to convert kind of into a higher volume user of IVL.
